Central core disease is a rare inherited neuromuscular disorder caused by mutations in ryanodine receptortype 1 gene. The clinical phenotype of the disease is highly variable. We report a Chinese pedigree with central core disease confirmed by the gene sequencing. All 3 patients in the family presented with mild proximal limb weakness. The serum level of creatine kinase was normal, and electromyography suggested myogenic changes. The histologic analysis of muscle biopsy showed identical central core lesions in almost all of the muscle fibers in the index case. Exon 90-106 in the C-terminal domain of the ryanodine receptor type 1 gene was amplified using polymerase chain reaction. One heterozygous missense mutation G14678A (Arg4893Gln) in exon 102 was identified in all 3 patients. This is the first report of a familial case of central core disease confirmed by molecular study in mainland China.
ShyGMMageeKR. A new congenital non-progressive myopathy. Brain. 1956;79:610–621.
2.
ZhouHYamaguchiNXuL. Characterization of recessive RYR1 mutations in core myopathies. Hum Mol Genet. 2006;15:2791–2803.
3.
ShepherdSEllisFHalsallJHopkinsPRobinsonR. RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene. J Med Genet. 2004;41:e33.
4.
ChanBChenSPWongWC. RYR1-related central core myopathy in a Chinese adolescent boy. Hong Kong Med J. 2011;17:67–70.
5.
QuinlivanRMMullerCRDavisM. Central core disease: clinical, pathological, and genetic features. Arch Dis Child. 2003;88:1051–1055.
6.
DavisMRHaanEJungbluthH. Principle mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul Disord. 2003;13:151–157.
7.
XuLWangYYamaguchiNPasekDAMeissnerG. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies. J Biol Chem. 2008;283:6321–6329.
8.
RamachandranSSerohijosAWXuLMeissnerGDokholyanNV. A structural model of the pore-forming region of the skeletal muscle ryanodine receptor (RYR1). PLoS Comput Biol. 2009;5:e1000367.
9.
DuGGKhannaVKGuoXHMacLennanDH. Central core disease mutations R4892 W, I4897 T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release. Biochem J. 2004;382:557–564.
10.
RossiDDe SmetPLyfenkoA. A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibers. J Med Genet. 2007;44:e67.
11.
DirksenRTAvilaG. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys J. 2004;87:3193–3204.
12.
ZhouHJungbluthHSewryCA. Molecular mechanisms and phenotypic variation in RyR1-ralated congenital myopathies. Brain. 2007;130:2024–2036.
13.
WuSIbarraMCMalicdanMC. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006;129:1470–1480.
14.
WuSMaWYuS. Clinicopathological features of 28 cases with central core disease. Chin J Neuromed. 2006;5:597–600.
15.
ZhuHShenJLeM. Central core disease: 2 cases report and review of the literature. J Clin Exp Pathol. 2001;17:494–496.
16.
JeongSKKimDCChoYGSunwooINKimDS. A double mutation of the ryanodine receptor type 1 gene in a malignant hyperthermia family with multiminicore myopathy. J Clin Neurol. 2008;4:123–130.
17.
ZhouHBrockingtonMJungbluthH. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am J Hum Genet. 2006;79:859–868.
18.
ZvaritchEKraevaNBombardierE. Ca2+ dysregulation in Ryr1 (I14985T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods. Proc Natl Acad Sci USA. 2009;106:21813–21818.
19.
GhassemiFVukcevicMXuL. A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity. Cell Calcium. 2009;45:192–197.
20.
LyfenkoADDucreuxSWangY. Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms. Hum Mutat. 2007;28:61–68.
21.
TilgenNZorzatoFHalliger-KellerB. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet. 2001;10:2879–2887.
